President and head, U.S. Commercial,
Sweeney leads Bristol-Myers Squibb's biopharma division, which generates 60% of the company’s business, totaling nearly $12 billion. She oversaw growth of key drugs, including blood thinners and antipsychotic medications. Sweeney advocated for real-world data and its application in drug development. Sweeney is also actively involved in the company's Network of Women program, which boasts 4,000 members, and mentors many of its members.